Skip to main content

MoneyWorks4Me

Wockhardt informs about press release

19 Sep 2024 Evaluate

Pursuant to Regulation 30 of Listing Regulations, Wockhardt has informed that it enclosed Press Release – ‘Wockhardt's Investigational Drug, Zaynich™ (Zidebactam/Cefepime) cures complex case of meningitis caused by pan-drug resistant super-bug under compassionate use’. A copy of the same will also be uploaded on the Company’s website www.wockhardt.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1880.90
Dr. Reddys Labs. 1377.00
Cipla 1393.00
Lupin 1980.00
Zydus Lifesciences 1191.00
View more..